Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chifeng Funakang Biotechnology is a high-tech enterprise specializing in the research, development, and industrialization of fullerene-based materials for the life sciences and healthcare sectors. Founded by scientists from the Chinese Academy of Sciences, the company operates a large-scale production facility for high-purity fullerenes and water-soluble fullerene derivatives. Its product portfolio spans across cosmetic ingredients, health supplements, and experimental pharmaceutical applications, leveraging the potent antioxidant properties of fullerenes. Funakang is recognized for its radical sponge technology, which targets oxidative stress-related conditions. The company maintains a strong R&D presence in Beijing while conducting large-scale manufacturing in Chifeng, Inner Mongolia. It holds a significant patent portfolio in the field of nanotechnology and carbon-based nanomaterials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 赤峰福纳康生物技术.